{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T06:30:09Z","timestamp":1775197809064,"version":"3.50.1"},"reference-count":32,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["SA51-006646"],"award-info":[{"award-number":["SA51-006646"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Sex Transm Infect"],"published-print":{"date-parts":[[2022,5]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>STIs are a major public health concern. Screening programmes for asymptomatic users are key components of STI control. Traditional limitations of screening programmes include low population coverage and delays in treatments, thus reducing the expected impact on STI control. In our centre, the normal time from test to results was 4 days, and 7 days until treatment was established.<\/jats:p><jats:p>To reduce time to treatment and to increase population coverage, we developed \u2018Drassanes Expr\u00e9s\u2019, a testing service for asymptomatic STIs. The objectives of this study were to provide a guide for the implementation of a service with these characteristics and to evaluate the results of this intervention.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The Drassanes Expr\u00e9s programme was launched in Spain on 07 November 2016 as a public, confidential and free-of-charge testing service for asymptomatic STIs, with same-day result notification. For this walk-in service, confidentiality was obtained by registering all information into the Laboratory Internal Software instead of the Electronic Patient Records. Samples were processed in a point-of-care laboratory and result notification was provided via mail or short message service.<\/jats:p><jats:p>Information about workflow, screening protocols and result interpretation is detailed. Additionally, demographic characteristics, STI prevalence, and time from patients\u2019 sample collection to notification and treatment are analysed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Between 07 November 2016 and 07 November 2019, 13\u2009993 users attended the Drassanes Expr\u00e9s screening programme. Of these, 0.5% were transgender people, 29.3% women, 45.2% men who have sex with men and 25.1% men who have sex with women. The median age was 31 years (range: 26\u201339 years). Overall, 14.6% of users tested positive for at least one STI. The most prevalent infection was <jats:italic>Chlamydia trachomatis<\/jats:italic> (8.3%), followed by <jats:italic>Neisseria gonorrhoeae<\/jats:italic> (5.7%), syphilis (1.8%), HIV (0.4%) and hepatitis C virus (0.2%). The median time from test to results was 2.4 hours (range: 2\u20133.1\u2009hours). Of 2049 users diagnosed with an STI, treatment was achieved in 97.0% of cases; the average time to treatment was 2.0 days.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Drassanes Expr\u00e9s is the first public programme for rapid, asymptomatic, STI screening and treatment in Spain. Assessing high-risk practices and providing confidentiality, easy access and rapid results\/treatments are key elements in the development of STI screening programmes.<\/jats:p><\/jats:sec>","DOI":"10.1136\/sextrans-2020-054779","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T17:31:14Z","timestamp":1618248674000},"page":"166-172","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Drassanes Expr\u00e9s: a public and confidential testing service for asymptomatic STIs with same-day result notification"],"prefix":"10.1136","volume":"98","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6354-0149","authenticated-orcid":false,"given":"Yannick","family":"Hoyos-Mallecot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge Nestor","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Sulleiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliana","family":"Esperalba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Salmeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesc","family":"Zarzuela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maider","family":"Arando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Descalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mart\u00ed","family":"Vall-Mayans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"Barber\u00e1","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4798-2385","authenticated-orcid":false,"given":"Judit","family":"Serra-Pladevall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"LLinas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benito","family":"Almirante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Pumarola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4822-1024","authenticated-orcid":false,"given":"Mateu","family":"Espasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"key":"2022100410401139000_98.3.166.1","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.18.228486"},{"key":"2022100410401139000_98.3.166.2","unstructured":"Centre d\u2019Estudis Epidemiol\u00f2gics sobre les Infeccions de Transmissi\u00f3 Sexual i Sida de Catalunya (CEEISCAT) . Vigil ncia epidemiol\u00f2gica de les infeccions de transmissi\u00f3 sexual a Catalunya Informe anual 2017. Badalona: CEEISCAT, 2018. Available: https:\/\/www.idescat.cat\/serveis\/biblioteca\/docs\/bib\/pec\/paae2018\/gi18982017act191118.pdf [Accessed 26 Mar 2020]."},{"key":"2022100410401139000_98.3.166.3","doi-asserted-by":"crossref","first-page":"e396","DOI":"10.1016\/S2352-3018(19)30043-8","article-title":"Epidemiology and prevention of sexually transmitted infections in men who have sex with men at risk of HIV","volume":"6","author":"Chow","year":"2019","journal-title":"Lancet HIV"},{"key":"2022100410401139000_98.3.166.4","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pop.2018.10.013","article-title":"Screening for sexually transmitted diseases","volume":"46","author":"Levy","year":"2019","journal-title":"Prim Care"},{"key":"2022100410401139000_98.3.166.5","unstructured":"National Center for HIV\/AIDS, Viral Hepatitis, STD, and TB Prevention (US) Division of STD Prevention . Sexually transmitted disease surveillance 2018. CDC, 2019."},{"key":"2022100410401139000_98.3.166.6","doi-asserted-by":"publisher","DOI":"10.1097\/OLQ.0b013e318285c6d2"},{"key":"2022100410401139000_98.3.166.7","doi-asserted-by":"publisher","DOI":"10.1136\/sti.2007.026641"},{"key":"2022100410401139000_98.3.166.8","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.rr6404a1"},{"key":"2022100410401139000_98.3.166.9","first-page":"907","article-title":"Sexually transmitted infections: recommendations from the U.S. preventive services Task force","volume":"94","author":"Lee","year":"2016","journal-title":"Am Fam Physician"},{"key":"2022100410401139000_98.3.166.10","unstructured":"Australian Sexual Health Alliance . Australian STI management guidelines for use in primary care. Available: http:\/\/www.sti.guidelines.org.au\/standard-asymptomatic-check-up [Accessed 26 Mar 2020]."},{"key":"2022100410401139000_98.3.166.11","doi-asserted-by":"publisher","DOI":"10.1258\/ijsa.2012.200312"},{"key":"2022100410401139000_98.3.166.12","unstructured":"Grupo de Expertos del Grupo de Estudio de Sida de la SEIMC (GESIDA), Secreta-ria del Plan Nacional sobre el Sida (SPNS), Grupo de Estudio de ITS de la SEIMC(GEITS), Grupo Espa\u00f1ol para la Investigaci\u00f3n de las Enfermedades de Transmisi\u00f3n Sexual de la Academia Espa\u00f1ola de Dermatolog\u00eda y Venerolog\u00eda y de laSociedad Espa\u00f1ola de Infectolog\u00eda Pedi\u00e1trica (SEIP) . Documento de Consenso Sobre Diagn\u00f3stico Y Tratamiento de las Infecciones de Transmisi\u00f3n sexual en Adultos, Ni\u00f1os Y Adolescentes (marzo 2017). Available: https:\/\/www.seimc.org\/contenidos\/gruposdeestudio\/geits\/pcientifica\/documentos\/geits-dc-ITS-201703.pdf [Accessed 26 Mar 2020]."},{"key":"2022100410401139000_98.3.166.13","doi-asserted-by":"publisher","DOI":"10.1086\/589883"},{"key":"2022100410401139000_98.3.166.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.05.011"},{"key":"2022100410401139000_98.3.166.15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1111\/1753-6405.12680","article-title":"Barriers to sexually transmitted infection testing in New Zealand: a qualitative study","volume":"41","author":"Denison","year":"2017","journal-title":"Aust N Z J Public Health"},{"key":"2022100410401139000_98.3.166.16","unstructured":"Buitendam E . Audit report on turnaround times: national Chlamydia screening. Available: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/380604\/NCSP_audit_report_turnaround_times.pdf [Accessed 26 Mar 2020]."},{"key":"2022100410401139000_98.3.166.17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/OLQ.0b013e3181a819db","article-title":"Characteristics of men who have sex with men and women and women who have sex with women and men: results from the 2003 Seattle sex survey","volume":"36","author":"Levin","year":"2009","journal-title":"Sex Transm Dis"},{"key":"2022100410401139000_98.3.166.18","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1177\/0956462417736431","article-title":"Rapid testing and treatment for sexually transmitted infections improve patient care and yield public health benefits","volume":"29","author":"Whitlock","year":"2018","journal-title":"Int J STD AIDS"},{"key":"2022100410401139000_98.3.166.19","doi-asserted-by":"publisher","DOI":"10.1136\/bmjqs-2015-004411"},{"key":"2022100410401139000_98.3.166.20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/ajcp\/aqy153","article-title":"Analytical and clinical performance evaluation of the Elecsys HIV combi Pt assay on the COBAS E 602 analyzer for the diagnosis of human immunodeficiency virus","volume":"151","author":"Uettwiller-Geiger","year":"2019","journal-title":"Am J Clin Pathol"},{"key":"2022100410401139000_98.3.166.21","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.23536"},{"key":"2022100410401139000_98.3.166.22","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ijid.2018.12.016","article-title":"Evaluation of the Elecsys syphilis electrochemiluminescence immunoassay as a first-line screening test in the reverse algorithms for syphilis serodiagnosis","volume":"80","author":"Lee","year":"2019","journal-title":"Int J Infect Dis"},{"key":"2022100410401139000_98.3.166.23","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1128\/jcm.16.2.286-290.1982","article-title":"Evaluation of a new rapid plasma reagin card test as a screening test for syphilis","volume":"16","author":"Perryman","year":"1982","journal-title":"J Clin Microbiol"},{"key":"2022100410401139000_98.3.166.24","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1071\/SH18079","article-title":"Meta-analysis of the Cepheid Xpert\u00ae CT\/NG assay for extragenital detection of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections","volume":"16","author":"Bristow","year":"2019","journal-title":"Sex Health"},{"key":"2022100410401139000_98.3.166.25","first-page":"30448","article-title":"Evaluation of four commercial real-time PCR assays for the detection of lymphogranuloma venereum in Chlamydia trachomatis-positive anorectal samples","author":"Touati","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"2022100410401139000_98.3.166.26","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.pcl.2016.11.008","article-title":"Adolescent sexuality","volume":"64","author":"Wangu","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"2022100410401139000_98.3.166.27","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-3694-z","article-title":"Preventing sexually transmitted and blood borne infections (STBBIs) among sex workers: a critical review of the evidence on determinants and interventions in high-income countries","volume":"19","author":"Argento","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2022100410401139000_98.3.166.28","doi-asserted-by":"crossref","DOI":"10.1186\/s40985-018-0093-8","article-title":"Assessing the value of screening tools: reviewing the challenges and opportunities of cost-effectiveness analysis","volume":"39","author":"Iragorri","year":"2018","journal-title":"Public Health Rev"},{"key":"2022100410401139000_98.3.166.29","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051626"},{"key":"2022100410401139000_98.3.166.30","doi-asserted-by":"publisher","DOI":"10.1177\/0956462415591414"},{"key":"2022100410401139000_98.3.166.31","doi-asserted-by":"publisher","DOI":"10.1136\/sextrans-2014-051580"},{"key":"2022100410401139000_98.3.166.32","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.4819","article-title":"Evaluation of the performance of a point-of-care test for Chlamydia and gonorrhea","volume":"3","author":"Van Der Pol","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["Sexually Transmitted Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/sextrans-2020-054779","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,4]],"date-time":"2022-10-04T17:42:06Z","timestamp":1664905326000},"score":1,"resource":{"primary":{"URL":"https:\/\/sti.bmj.com\/lookup\/doi\/10.1136\/sextrans-2020-054779"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":32,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2022,4,12]]},"published-print":{"date-parts":[[2022,5]]}},"alternative-id":["10.1136\/sextrans-2020-054779"],"URL":"https:\/\/doi.org\/10.1136\/sextrans-2020-054779","relation":{},"ISSN":["1368-4973","1472-3263"],"issn-type":[{"value":"1368-4973","type":"print"},{"value":"1472-3263","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]}}}